Organonitrogen Compounds
Research Products International Corp Murashige and Skoog Medium with Vitamins, Van der Salm Modification, 44 Grams of Powder, Makes 10 Liters of Solution
Basal salt mixture containing micro and macro elements as described by Murashige & Skoog (1962). Modified by replacing FeNaEDTA with FeEDDHA as described by Van der Salm et. al. (1994).
- Concentration: 4464.49 mg/L
- Hygroscopic
Chem-Impex International, Inc. 2-(Dimethylamino)ethylamine | MFCD00008175 | 100G
2-(Dimethylamino)ethylamine, MFCD00008175, 100G
Cayman Chemical 5-NItroso-8-quInolInol 100mg
An HDAC inhibitor, antitumor agent that at 10 μM can induce oxidative stress contributing to apoptosis and differentiation in MCF-7 breast cancer cells; inhibits T. gondii tachyzoite propagation in human fibroblasts (EC50 = 80 nM) and inhibits P. falciparum growth in human red blood cells (EC50 = 1.3 μM)
Medchemexpress LLC Tetrabutylammonium trifluoromethanesulfonate | 35895-70-6 | MFCD00042585 | 98.0% | 391.53 g/mol | C17H36F3NO3S | 10 G
Tetrabutylammonium trifluoromethanesulfonate is a quaternary ammonium salt used as a reagent and phase-transfer catalyst in organic synthesis and biochemical assays. It provides a lipophilic tetrabutylammonium cation paired with a non-coordinating trifluoromethanesulfonate anion, enabling solubilization of ionic species in organic media.
- Purity 98.0%.
- Molecular weight 391.53 g/mol.
- Chemical formula C17H36F3NO3S.
- CAS number 35895-70-6.
- Store at 4°C, sealed and away from moisture.
- Available in small pack sizes for laboratory use.
![eMolecules 61551-69-7 | 2,2'-Azobis[2-methyl-n-(2-hydroxyethyl)propionamide] | Combi-Blocks, Inc. | MFCD00142728 | 288.348 | C12H24N4O4 | 98.000 | CC(C)(\N=N\C(C)(C)C(=O)NCCO)C(=O)NCCO | 25g | 818522541](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000164481.jpg-250.jpg)
eMolecules 61551-69-7 | 2,2'-Azobis[2-methyl-n-(2-hydroxyethyl)propionamide] | Combi-Blocks, Inc. | MFCD00142728 | 288.348 | C12H24N4O4 | 98.000 | CC(C)(\N=N\C(C)(C)C(=O)NCCO)C(=O)NCCO | 25g | 818522541
2,2'-Azobis[2-methyl-n-(2-hydroxyethyl)propionamide] | Combi-Blocks, Inc. | 61551-69-7 | MFCD00142728 | 288.348 | C12H24N4O4 | 98.000 | CC(C)(\N=N\C(C)(C)C(=O)NCCO)C(=O)NCCO | 25g | 818522541
eMolecules 180869-39-0 | 2-(METHYLAMINO)PYRIMIDINE-4-CARBOXALDEHYDE | MFCD09999147 | 1g
Ambeed | (4R4R5R5R)-22-(23-Dihydro-1H-indene-22-diyl)bis(45-diphenyl-45-dihydrooxazole) | 100mg | 672838365 | A1508160 | 2757085-87-1 | 560.697 | C39H32N2O2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
![Medchemexpress LLC 4-naphthalen-1-yl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide | 353483-92-8 | MFCD01080566 | 99.8% | 376.47 | C22H20N2O2S | 50 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000240482.png-250.jpg)
Medchemexpress LLC 4-naphthalen-1-yl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide | 353483-92-8 | MFCD01080566 | 99.8% | 376.47 | C22H20N2O2S | 50 MG
TQS is a selective positive allosteric modulator of the α7 nicotinic acetylcholine receptor (nAChR) used in preclinical research, including studies of neuroinflammatory pain. It is provided as a high-purity research chemical and is available as a powder or as a DMSO solution for experimental use.
- Selective α7 positive allosteric modulator for receptor modulation studies.
- Suitable for in vitro and in vivo neuroinflammatory pain research.
- High purity (~99.8%).
- Available as powder and as a 10 mM solution in DMSO.
- Recommended storage: powder -20 °C long term or 4 °C short term; in solvent -80 °C.
- Molecular formula C22H20N2O2S and molecular weight 376.47 g·mol-1.
eMolecules 5388-21-6 | 2-(Methylamino)pyrimidine-5-carboxylic acid | Combi-Blocks, Inc. | MFCD08146593 | 153.141 | C6H7N3O2 | 97.000 | CNc1ncc(cn1)C(O)=O | 5g | 586076012
2-(Methylamino)pyrimidine-5-carboxylic acid | Combi-Blocks, Inc. | 5388-21-6 | MFCD08146593 | 153.141 | C6H7N3O2 | 97.000 | CNc1ncc(cn1)C(O)=O | 5g | 586076012
Medchemexpress LLC 2,2-Dihydroxy-1-phenylethan-1-one | 1075-06-5 | 97.0% | 25 G
2,2-Dihydroxy-1-phenylethan-1-one is an arylglyoxal monohydrate that serves as an intermediate in pharmaceutical synthesis. It possesses antioxidant properties and can be utilized as a starting material for the synthesis of aromatic or aliphatic amines.
- An arylglyoxal monohydrate.
- Intermediate for pharmaceutical synthesis.
- Exhibits antioxidant property.
- Starting material for synthesis of aromatic or aliphatic amines.
eMolecules 1015856-38-8 | 4-(ISOBUTYLAMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBOXYLIC ACID | AstaTech | MFCD09998272 | 241.310 | C10H15N3O2S | 95.000 | CSc1ncc(C(O)=O)c(NCC(C)C)n1 | 1g | 112532160
4-(ISOBUTYLAMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBOXYLIC ACID | AstaTech | 1015856-38-8 | MFCD09998272 | 241.310 | C10H15N3O2S | 95.000 | CSc1ncc(C(O)=O)c(NCC(C)C)n1 | 1g | 112532160
Medchemexpress LLC RP-1664 | 2980682-00-4 | 98.77% | 514.55 | 5 MG
RP-1664 is a selective and orally active PLK4 inhibitor with an IC50 of 3 nM. It demonstrates selectivity over related kinases like AURKA/B and PLK1. This compound disrupts centriole biogenesis in cancer cells, leading to an accumulation of PLK4 and p21 protein. RP-1664 shows increased sensitivity in TRIM37-high-expressing cells or tumors and exhibits anti-tumor activity in breast cancer and neuroblastoma research.